Table 3.
COVID-19 outcome by demographic characteristics.
| N | Alive | Dead | P-value | ||
|---|---|---|---|---|---|
| 54 | % or SD | 10 | % or SD | ||
| Early vs Advanced BC | 4 | 7% | 4 | 40% | .019 |
| Age (mean [SD]) | 58.29 | 13.56 | 73.16 | 8.33 | .001 |
| AgeBand % | .001 | ||||
| [20,44] | 6 | 11% | 0 | 0% | |
| (44,54] | 17 | 32% | 0 | 0% | |
| (54,64] | 16 | 30% | 1 | 10% | |
| (64,74] | 11 | 20% | 4 | 40% | |
| (74,120] | 4 | 7% | 5 | 50% | |
| BMI (mean [SD]) | 29.16 | 5.81 | 33.45 | 8.53 | .051 |
| Race (%) | .067 | ||||
| Asian | 2 | 4% | 0 | 0 | |
| Black | 15 | 28% | 3 | 30% | |
| Hispanic | 0 | 0% | 1 | 10% | |
| Native Hawaiian or Other Pacific Islander | 2 | 4% | 0 | 0% | |
| Other | 8 | 15% | 0 | 0% | |
| Patient Refused | 1 | 2% | 0 | 0% | |
| Unknown | 0 | 0% | 1 | 10% | |
| White | 26 | 48% | 5 | 50% | |
| Charlson Comorbidity Index (mean [SD]) | 3.37 | 3.13 | 6.1 | 3.14 | .014 |
| Charlson Comorbidity Index (median [IQR]) | 2 | (2-7) | 7 | (3-8) | .006 |
Early breast cancer (BC) – Stage I, II, III Advanced BC – Stage IV. Bracket symbol indicates outside value, Parenthesis excludes outside value.